A decade of sustained geographic spread of HIV infections among women in Durban, South Africa.
HIV
Heterogeneity
Incidence
Mapping
Risk factors
Spatial epidemiology
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
07 Jun 2019
07 Jun 2019
Historique:
received:
02
07
2018
accepted:
13
05
2019
entrez:
9
6
2019
pubmed:
9
6
2019
medline:
8
8
2019
Statut:
epublish
Résumé
Fine scale geospatial analysis of HIV infection patterns can be used to facilitate geographically targeted interventions. Our objective was to use the geospatial technology to map age and time standardized HIV incidence rates over a period of 10 years to identify communities at high risk of HIV in the greater Durban area. HIV incidence rates from 7557 South African women enrolled in five community-based HIV prevention trials (2002-2012) were mapped using participant household global positioning system (GPS) coordinates. Age and period standardized HIV incidence rates were calculated for 43 recruitment clusters across greater Durban. Bayesian conditional autoregressive areal spatial regression (CAR) was used to identify significant patterns and clustering of new HIV infections in recruitment communities. The total person-time in the cohort was 9093.93 years and 613 seroconversions were observed. The overall crude HIV incidence rate across all communities was 6·74 per 100PY (95% CI: 6·22-7·30). 95% of the clusters had HIV incidence rates greater than 3 per 100PY. The CAR analysis identified six communities with significantly high HIV incidence. Estimated relative risks for these clusters ranged from 1.34 to 1.70. Consistent with these results, age standardized HIV incidence rates were also highest in these clusters and estimated to be 10 or more per 100 PY. Compared to women 35+ years old younger women were more likely to reside in the highest incidence areas (aOR: 1·51, 95% CI: 1·06-2·15; aOR: 1.59, 95% CI: 1·19-2·14 and aOR: 1·62, 95% CI: 1·2-2·18 for < 20, 20-24, 25-29 years old respectively). Partnership factors (2+ sex partners and being unmarried/not cohabiting) were also more common in the highest incidence clusters (aOR 1.48, 95% CI: 1.25-1.75 and aOR 1.54, 95% CI: 1.28-1.84 respectively). Fine geospatial analysis showed a continuous, unrelenting, hyper HIV epidemic in most of the greater Durban region with six communities characterised by particularly high levels of HIV incidence. The results motivate for comprehensive community-based HIV prevention approaches including expanded access to PrEP. In addition, a higher concentration of HIV related services is required in the highest risk communities to effectively reach the most vulnerable populations.
Sections du résumé
BACKGROUND
BACKGROUND
Fine scale geospatial analysis of HIV infection patterns can be used to facilitate geographically targeted interventions. Our objective was to use the geospatial technology to map age and time standardized HIV incidence rates over a period of 10 years to identify communities at high risk of HIV in the greater Durban area.
METHODS
METHODS
HIV incidence rates from 7557 South African women enrolled in five community-based HIV prevention trials (2002-2012) were mapped using participant household global positioning system (GPS) coordinates. Age and period standardized HIV incidence rates were calculated for 43 recruitment clusters across greater Durban. Bayesian conditional autoregressive areal spatial regression (CAR) was used to identify significant patterns and clustering of new HIV infections in recruitment communities.
RESULTS
RESULTS
The total person-time in the cohort was 9093.93 years and 613 seroconversions were observed. The overall crude HIV incidence rate across all communities was 6·74 per 100PY (95% CI: 6·22-7·30). 95% of the clusters had HIV incidence rates greater than 3 per 100PY. The CAR analysis identified six communities with significantly high HIV incidence. Estimated relative risks for these clusters ranged from 1.34 to 1.70. Consistent with these results, age standardized HIV incidence rates were also highest in these clusters and estimated to be 10 or more per 100 PY. Compared to women 35+ years old younger women were more likely to reside in the highest incidence areas (aOR: 1·51, 95% CI: 1·06-2·15; aOR: 1.59, 95% CI: 1·19-2·14 and aOR: 1·62, 95% CI: 1·2-2·18 for < 20, 20-24, 25-29 years old respectively). Partnership factors (2+ sex partners and being unmarried/not cohabiting) were also more common in the highest incidence clusters (aOR 1.48, 95% CI: 1.25-1.75 and aOR 1.54, 95% CI: 1.28-1.84 respectively).
CONCLUSION
CONCLUSIONS
Fine geospatial analysis showed a continuous, unrelenting, hyper HIV epidemic in most of the greater Durban region with six communities characterised by particularly high levels of HIV incidence. The results motivate for comprehensive community-based HIV prevention approaches including expanded access to PrEP. In addition, a higher concentration of HIV related services is required in the highest risk communities to effectively reach the most vulnerable populations.
Identifiants
pubmed: 31174475
doi: 10.1186/s12879-019-4080-6
pii: 10.1186/s12879-019-4080-6
pmc: PMC6555962
doi:
Types de publication
Journal Article
Langues
eng
Pagination
500Subventions
Organisme : NIAID NIH HHS
ID : U01 AI048008
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069422
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069422
Pays : United States
Références
AIDS. 2003 Apr 11;17(6):895-903
pubmed: 12660537
Lancet. 2004 May 1;363(9419):1415-21
pubmed: 15121402
J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):333-9
pubmed: 15980695
Lancet. 2007 Jul 21;370(9583):251-261
pubmed: 17631387
J Adv Nurs. 2007 Nov;60(4):377-83
pubmed: 17822425
Int J Epidemiol. 2008 Oct;37(5):956-62
pubmed: 17998242
Am J Trop Med Hyg. 2007 Dec;77(6):1163-9
pubmed: 18165541
AIDS. 2008 Mar 30;22(6):741-8
pubmed: 18356604
Lancet. 2008 Aug 30;372(9640):764-75
pubmed: 18687460
Lancet. 2008 Dec 6;372(9654):1977-87
pubmed: 19059048
Lancet. 2010 Jul 3;376(9734):41-8
pubmed: 20557928
Science. 2010 Sep 3;329(5996):1168-74
pubmed: 20643915
Lancet. 2010 Oct 16;376(9749):1329-37
pubmed: 20851460
Biometrics. 1990 Dec;46(4):1171-8
pubmed: 2085632
J Int AIDS Soc. 2010 Oct 27;13:41
pubmed: 20979651
Int J Epidemiol. 2011 Aug;40(4):922-30
pubmed: 21047913
AIDS. 2011 Apr 24;25(7):957-66
pubmed: 21330907
Int J Health Geogr. 2011 Apr 17;10:28
pubmed: 21496324
Lancet. 2011 Jul 16;378(9787):247-55
pubmed: 21763937
AIDS. 2011 Sep 24;25(15):1887-95
pubmed: 21785321
J Infect Dis. 2011 Oct 1;204(7):1115-9
pubmed: 21881127
BMJ Open. 2012 Jan 05;2:e000285
pubmed: 22223838
J Infect Dis. 2012 Jul 1;206(1):6-14
pubmed: 22517910
PLoS One. 2012;7(4):e35278
pubmed: 22536364
N Engl J Med. 2012 Aug 2;367(5):423-34
pubmed: 22784038
Trials. 2013 Feb 01;14:33
pubmed: 23374729
Science. 2013 Feb 22;339(6122):966-71
pubmed: 23430656
Int J Health Geogr. 2013 May 22;12:28
pubmed: 23692994
Curr Opin HIV AIDS. 2014 Mar;9(2):115-25
pubmed: 24356328
BMC Infect Dis. 2014 May 23;14:285
pubmed: 24886573
AIDS Res Ther. 2014 Sep 15;11:31
pubmed: 25243015
N Engl J Med. 2015 Feb 5;372(6):509-18
pubmed: 25651245
Afr J AIDS Res. 2005 May;4(1):37-50
pubmed: 25865640
N Engl J Med. 2016 Dec;375(22):2121-2132
pubmed: 26900902
PLoS One. 2016 Apr 22;11(4):e0153969
pubmed: 27104835
AIDS. 2017 Jan 2;31(1):137-145
pubmed: 27755099
Lancet HIV. 2017 Jan;4(1):e41-e50
pubmed: 27914874
Am J Reprod Immunol. 2017 Mar;77(3):
pubmed: 28111861
J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):318-325
pubmed: 28187085
Science. 2017 Jun 2;356(6341):938-945
pubmed: 28572388
AIDS. 2017 Jul 31;31(12):1755-1764
pubmed: 28590328
Int J Epidemiol. 2018 Apr 1;47(2):537-549
pubmed: 29300904
Nurs RSA. 1994 Sep;9(9):20-1
pubmed: 7715676
Sex Transm Dis. 1998 Jan;25(1):20-3
pubmed: 9437780